Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sara Modig has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Safe Handover or Lost in Transition?—A Retrospective Evaluation of Pharmacist Referrals to Primary Care Following Hospital Discharge

    by Katarina Wickman, Cecilia Lenander, Gabriella Caleres, Sara Modig

    The medication-related problems identified by clinical pharmacists during hospitalisation may be better addressed after patient discharge and recovery from acute illness. This approach enables follow-up and may reduce the risks associated with multiple medication changes. However, inadequate information transfer at discharge is a recognised patient safety risk. Referral-based communication between clinical pharmacists and general practitioners (GPs) is a novel procedure in southern Sweden. This retrospective observational study aimed to describe the patient population, medication-related problems, their clinical relevance, and resulting GP actions. Data were collected from pharmacist referrals and electronic medical records between Q4 2021 and Q4 2023. Medication-related problems were categorised, recommendations were assessed for clinical relevance, and follow-up within six months after discharge was analysed to determine whether GPs accepted the recommendations. Forty patients with 58 medication-related problems were included. Women accounted for 70% of the patients, the median age was 79.5 years, and 75% had extensive polypharmacy. Adherence problems were most common (22%). Overall, 98% of the recommendations were considered clinically relevant. Of the 48 assessable recommendations, 77% were implemented in primary care. No statistical association between clinical relevance and implementation was detected (odds ratio 2.27, p = 0.247, CI 0.57–9.04). Pharmacist referrals at discharge may support information transfer and provide clinically relevant recommendations that improve medication safety.

  • Open Access

    An Underused Competence: Clinical Pharmacists’ Experiences of Writing Referrals in Transitions of Care

    by Katarina Wickman, Sara Modig, Cecilia Lenander, Gabriella Caleres

    Older people are at increased risk of medication-related problems, which may be identified by clinical pharmacists during hospital medication reviews. Some problems are better managed in primary care, where follow-up is possible. Medication-related communication by pharmacists may improve information transfer in care transitions, but this practice remains uncommon in Sweden. This qualitative study explored clinical pharmacists’ experiences and perceptions of writing referrals to primary care. Data were collected through four focus groups and three supplementary interviews with 19 clinical pharmacists from hospitals and primary care, and analysed using qualitative content analysis. Eleven participants had experience writing referrals, although none did so regularly. Four categories emerged: role of the pharmacist, current work procedures, pharmacist–physician relationship and facilitating factors. Pharmacists believe they can contribute to patient safety through involvement in transitions of care. An overall concept of an underused competence permeated the categories. Referrals identifying medication-related problems are hindered by limited pharmacist integration into the healthcare team and limited continuity. Writing referrals was considered a new procedure requiring collaboration with unfamiliar partners. Organisational changes, including increased pharmacist continuity and clearer pharmacist roles, are needed to implement referral practices. Further research is needed to evaluate effects on medication treatment and patient outcomes.


  • Open Access

    Nurses’ perspectives on medication safety for Swedish community-dwelling older adults in primary care

    by Gabriella Caleres, Sarah Thelin, Elisabeth Persson, Veronica Milos Nymberg, Sara Modig

    To improve care for community-dwelling older individuals, Swedish primary care has implemented nurse-led elderly care units targeting this group. To explore how primary care nurses working in elderly care units view their role regarding medication safety and gain their perspectives on the work model. This was a qualitative focus group study with 14 strategically sampled primary care nurses working at elderly care units. Data were collected through three focus groups and two individual interviews between September 2024 and June 2025, audio-recorded and transcribed verbatim. Content analysis was applied, and the person-centred nursing framework was used to interpret the results. Triangulation and reflexivity were pursued, and an audit trail was maintained to ensure trustworthiness. Five categories emerged (1), diverse conditions for elderly care units (2), preventing and managing drug-related problems (3), bridging the gap - a vital function for medication safety (4), the comprehensive geriatric perspective, and (5) perceptions of the nurse's role. This study found that nurses in elderly care units recognize their potentially significant role in medication safety. Their comprehensive geriatric perspective enables them to impede or intervene on drug-related problems, compensate for fragmented care and resolve issues as a central coordinator. However, the absence of guidelines leads to inconsistent and inequitable care, insights important for further development of the work model.

  • Open Access

    ‘You get a different mindset’ – primary care physicians’ perceptions of interprofessional medication reviews for patients living independently

    by Annika Dobszai, Sara Modig, Cecilia Lenander, Beata Borgström Bolmsjö

    In primary health care in southern Sweden, interprofessional medication reviews are conducted, to a limited extent, for patients living independently, with the purpose of optimising their pharmacological treatment. These medication reviews have identified and addressed many important issues regarding the patients' medication. However, there is limited knowledge regarding the participating physicians' perspectives on the work. Gaining a better understanding of the physicians' perspectives could contribute to the optimisation of the interprofessional medication review model used in primary health care. This study aimed to explore physicians' perceptions and experiences of interprofessional medication reviews in primary health care for patients who live independently. We conducted a qualitative study based on semi-structured discussions in four focus groups with a total of 24 participating primary care physicians. The discussions were transcribed verbatim, condensed, coded and categorised using content analysis. Through our analysis, we identified four categories: obstacles and facilitators, interprofessional collaboration with the pharmacist, the physician's responsibility and value-adding aspects. An underlying theme, a value-creating intervention with logistical barriers, emerged from the latent material. Physicians expressed a consistently positive view of medication reviews for independently living patients, highlighting their value for patient safety, clinical decision-making, and learning. However, practical barriers, such as time constraints and unclear routines, were seen as key obstacles to implementation. These findings reflect the dual nature of medication reviews as a value-creating intervention with logistical challenges, which need to be addressed to support broader integration in primary care.


  • Open Access

    How prone are Swedish general practitioners to perform medication reconciliation? A theory-based survey study

    by Sarah Thelin, Sara Modig, Veronica Milos Nymberg

    Background: Drug-related problems are common in older individuals. A medication reconciliation has the goal of identifying and maintaining an accurate medication list and can serve to prevent drug-related problems caused by discrepancies. Objectives: This study aimed to explore primary care physicians’ intentions towards performing medication reconciliation in patients with multimorbidity using a theory-based questionnaire. Design: A survey study was conducted from February to March 2024. Methods: An anonymous web-based questionnaire was developed, validated and distributed to 674 primary care physicians in southern Sweden. The questionnaire targeted attitudes, perceived norms, perceived behavioural control and generalised intentions towards performing a medication reconciliation, constructs derived from the theory of planned behaviour and the reasoned action approach theory. Outcome measures were overall scores for predictors, and the correlation between predictors and intentions towards performing a medication reconciliation was analysed using a multiple linear regression model. Results: With 206 surveys answered, the response rate was 31%. We found items targeting attitudes to have the highest overall mean score on a seven-point Likert scale (6.42), followed by generalised intention (6.17), subjective norms (5.45) and perceived behavioural control (5.15). Women had significantly higher scores for attitudes ( p -value 0.001), subjective norms ( p -value 0.050) and generalised intention ( p -value 0.001). Groups with more than 10 years of work experience had significantly higher overall mean scores for perceived behavioural control ( p -value 0.043). The correlation between predictors and generalised intention found attitudes and perceived behavioural control to be significant predictors of intentions to perform medication reconciliation in multimorbid older individuals ( p -value < 0.001). Conclusion: We found attitudes and perceived behavioural control to be significant predictors of primary care physicians’ intention to perform a medication reconciliation in patients with multimorbidity. These findings provide important insights into how future interventions targeting behavioural predictors can be developed.

  • Open Access

    Women’s experience of gestational diabetes and healthcare in southern Sweden – a qualitative study

    by Amanda Björk Javanshiri, Sara Modig, Peter Nymberg, Susanna Calling

    Background: Gestational diabetes is one of the most common pregnancy complications, affecting 14% of all pregnancies globally, and its prevalence is increasing. Gestational diabetes is associated with short and long-term complications for both the mother and their offspring, which are possible to prevent by glycemic control mainly facilitated by healthy lifestyle behaviors. Hence, women diagnosed with gestational diabetes have a significant role in disease management which can be perceived as burdensome. Previous research has well documented the psychological implications of diagnosis in the women and the need for support from healthcare. Despite the global burden of disease associated with gestational diabetes, recent qualitative studies exploring women's experiences are scarce, particularly in Sweden. Thus, highlighting a critical gap in understanding the impact of this condition and the women's experiences of diagnosis and prenatal healthcare, which this study aimed to address. Methods: Purposive sampling was used to recruit women with previous gestational diabetes in southern Sweden. Individual interviews were held with 17 participants according to a semi-structured interview guide. The interviews were audio recorded and transcribed verbatim. Data analysis was conducted according to qualitative content analysis. Results: The analysis generated 10 subcategories, which were grouped into three categories labeled: “experience of diagnosis”, “a complex relationship with food” and “experience of prenatal healthcare”. One theme emerged: to suddenly become a patient as opposed to an expectant mother. Most women were initially overwhelmed by the diagnosis and its consequences. They felt that healthy eating was important, despite it limiting their everyday lives, which also revealed a complicated relationship with food. Women felt supported during pregnancy but abandoned after labor. They requested additional information and emotional support from healthcare personnel, increased awareness and understanding of the treatment burden of gestational diabetes, improved person-centered care, and collaboration between healthcare providers, particularly to ensure better support in reducing future risk of disease. Conclusions: This study provides an understanding of women’s experience of gestational diabetes and the care provided in southern Sweden. Their views could improve future care regarding both successful gestational diabetes management and post-pregnancy follow-up to prevent long-term adverse health outcomes.


  • Open Access

    Clinical impact of medication reviews for community-dwelling patients in primary healthcare

    by Annika Dobszai, Cecilia Lenander, Beata Borgström Bolmsjö, Katarina Wickman, Sara Modig

    Background: A high number of drug-related problems has previously been shown among community-dwelling patients in primary healthcare in Skåne County, Sweden. Medication reviews are one way to solve these problems, but their impact is largely dependent on the process. We aimed to evaluate medication reviews for community-dwelling patients regarding the clinical relevance of the pharmacists’ recommendations, and their implementation by general practitioners. We also wanted to investigate if the general practitioners’ tendency to act on drug-related problems was correlated to different factors of the process. Methods: This was a cohort study, where patients in primary healthcare considered in need of a medication review were selected. Pharmacists identified drug-related problems and gave written recommendations on how to solve the problems to the general practitioner, via the medical record, and in addition in some cases via verbal communication. The clinical relevance of the recommendations was graded according to the Hatoum scale, ranging from one (adverse significance) to six (extremely significant). Descriptive statistics were used regarding the clinical relevance and the general practitioners´ tendency to act on drug-related problems. Multiple logistic regression analysis was used to examine the association between the tendency to act and different factors of the process. Results: A total of 96.1% of the 384 assessed recommendations from the pharmacists were graded as significant or more for the patient (Hatoum grade 3 or higher). The general practitioners acted on 63.8% of the drug-related problems. Fewer recommendations per patient, as well as verbal communication in addition to written contact, significantly increased the general practitioners’ tendency to act on a drug-related problem. No significant association was seen between the tendency to act and the clinical relevance of the recommendation. Conclusions: The high proportion of clinically relevant recommendations from the pharmacists in this study strengthens medication reviews as an important tool for reducing drug-related problems. Verbal communication between the pharmacist and the general practitioner is important for measures to be taken. Multiple recommendations for the same patient reduced their likelihood to of being addressed by the general practitioner.


  • Open Access

    Development of the Swedish anticholinergic burden scale (Swe-ABS)

    by Tanja Rube, Astrid Ecorcheville, Elisabet Londos, Sara Modig, Per Johansson

    Background: Drugs with anticholinergic properties are associated with cognitive adverse effects, especially in patients vulnerable to central muscarinic antagonism. A variety of drugs show weak, moderate or strong anticholinergic effects. Therefore, the cumulative anticholinergic burden should be considered in patients with cognitive impairment. This study aimed to develop a Swedish Anticholinergic Burden Scale (Swe-ABS) to be used in health care and research. Methods: A systematic literature review was conducted in PubMed and Ovid Embase to identify previously published tools quantifying anticholinergic drug burden (i.e., exposure). Drugs and grading scores (0–3, no to high anticholinergic activity) were extracted from identified lists. Enteral and parenteral drugs authorized in Sweden were included. Drugs with conflicting scores in the existing lists were assessed by an expert group. Two drugs that were not previously assessed were also added to the evaluation process. Results: The systematic literature search identified the following nine anticholinergic burden scales: Anticholinergic Activity Scale, Anticholinergic Burden Classification, updated Anticholinergic Cognitive Burden scale, Anticholinergic Drug Scale, Anticholinergic Load Scale, Anticholinergic Risk Scale, updated Clinician-rated Anticholinergic Scale, German Anticholinergic Burden Scale and Korean Anticholinergic Burden Scale. A list of drugs with significant anticholinergic effects provided by The Swedish National Board of Health and Welfare was included in the process. The suggested Swe-ABS consists of 104 drugs scored as having weak, moderate or strong anticholinergic effects. Two hundred and fifty-six drugs were listed as having no anticholinergic effects based on evaluation in previous scales. In total, 62 drugs were assessed by the expert group. Conclusions: Swe-ABS is a simplified method to quantify the anticholinergic burden and is easy to use in clinical practice. Publication of this scale might make clinicians more aware of drugs with anticholinergic properties and patients’ total anticholinergic burden. Further research is needed to validate the Swe-ABS and evaluate anticholinergic exposure versus clinically significant outcomes.


  • Open Access

    Pharmacist-led medication reviews in primary healthcare for adult community-dwelling patients – a descriptive study charting a new target group

    by Katarina Wickman, Annika Dobszai, Sara Modig, Beata Borgström Bolmsjö, Gabriella Caleres, Cecilia Lenander

    Medication treatment can reduce morbidity but can also cause drug-related problems (DRPs). One method to identify and solve DRPs is medication reviews (MRs) that are aimed at increased patient safety and quality in drug treatment. In Skåne county, Sweden, a well-established multi-professional model for MRs in nursing homes is practiced. However, a demand for MRs regarding community-dwelling patients has emerged. These patients may be extra vulnerable since they have less supervision from healthcare personnel. AIM: To describe the community-dwelling patients in primary healthcare considered in need of an MR, as well as the outcomes of these pharmacist-led MRs. Personnel from 14 primary healthcare centers selected patients for the MRs. Based on electronic medical records, the symptom assessment tool PHASE-20 (PHArmacotherapeutical Symptom Evaluation 20 questions) and medication lists, pharmacists conducted MRs and communicated adjustment suggestions via the medical record to the general practitioners (GPs). A total of 109 patients were included in the study and 90.8% (n = 99) of the patients were exposed to at least one DRP, with an average of 3.9 DRPs per patient. Patients with impaired renal function (glomerular filtration rate, GFR < 45 ml/min) or ≥ 10 medications were exposed to a significantly higher number of DRPs per patient, 5.1 DRP and 5.3 respectively. The most frequent DRP-categories were Unnecessary drug therapy and Adverse drug reaction, which represented 23.0% respectively 22.9% of the total amount of DRPs. Our results indicate a prioritized need for MRs for community-dwelling patients, specifically with impaired renal function or polypharmacy.